Header cover image
  • Investing Ideas
  • South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential

South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

1

0 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

ALTEOGEN

Market Cap: ₩19.8t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

A196170

₩369,500.00

7D

5.1%

1Y

10.5%